The Relationship between Ghrelin and Copeptin Levels, and Anxiety and Depression Levels in Suicide Attempts
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objective: It was aimed to detect acylated ghrelin (AG), unacylated ghrelin (UG) and copeptin levels in patients with suicide attempts and to determine if these biomarkers are risk factors for suicide attempts. Methods: Serum copeptin, AG and GU levels were screened in 128 patients who were admitted to emergency department with suicide attempts and 59 healthy controls. Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) were applied simultaneously, and the data were compared statistically. Results: AG, UG and copeptin levels were higher in the patient group compared with the healthy control group. BAI scores of patients were found to be positively correlated with BDI scores. While there was a significant difference (p=0.0064) between psychiatric and non-psychiatric patients with suicide attempts in terms of BAI scores, there were no differences in BDI scores and levels of biomarkers. We found significantly increased BDI and BAI scores and increased levels of AG, UG and copeptin in psychiatric and non-psychiatric patients compared with healthy individuals. The specificities yielded by receiver operating characteristic curve analysis in patients with suicide attempts were as follows: 91.53% for AG, 72.88% for UG and 94.92% for copeptin. Conclusion: Serum levels of AG, UG and copeptin increase with increasing anxiety and depression in patients with suicide attempts. Increased levels of AG, UG and copeptin could be considered a risk factor for suicide attempts.
Abstract
Objective: It was aimed to detect acylated ghrelin (AG), unacylated ghrelin (UG) and copeptin levels in patients with suicide attempts and to determine if these biomarkers are risk factors for suicide attempts. Methods: Serum copeptin, AG and GU levels were screened in 128 patients who were admitted to emergency department with suicide attempts and 59 healthy controls. Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) were applied simultaneously, and the data were compared statistically. Results: AG, UG and copeptin levels were higher in the patient group compared with the healthy control group. BAI scores of patients were found to be positively correlated with BDI scores. While there was a significant difference (p=0.0064) between psychiatric and non-psychiatric patients with suicide attempts in terms of BAI scores, there were no differences in BDI scores and levels of biomarkers. We found significantly increased BDI and BAI scores and increased levels of AG, UG and copeptin in psychiatric and non-psychiatric patients compared with healthy individuals. The specificities yielded by receiver operating characteristic curve analysis in patients with suicide attempts were as follows: 91.53% for AG, 72.88% for UG and 94.92% for copeptin. Conclusion: Serum levels of AG, UG and copeptin increase with increasing anxiety and depression in patients with suicide attempts. Increased levels of AG, UG and copeptin could be considered a risk factor for suicide attempts.
참고문헌 (30)
- Jaeha Kim, "Characteristic Risk Factors Associated with Planned versus Impulsive Suicide Attempters", Clinical Psychopharmacology and Neuroscience, 13(3), pp.308~315 (2015), 대한정신약물학회
- Rich CL, "Similarities in diagnostic comorbidity between suicide among young people in Sweden and the United States", Acta Psychiatr Scand, 86, pp.335~339 (1992)
- Yong-Sil Kweon, "Characteristics of Drug Overdose in Young Suicide Attempters", Clinical Psychopharmacology and Neuroscience, 10(3), pp.180~184 (2012), 대한정신약물학회
- Connor TJ, "Depression, stress and immunological activation: the role of cytokines in depressive disorders", Life Sci, 62, pp.583~606 (1998)
- Davami MH, "Elevated IL-17and TGF- serum levels : a positive correlation between T-helper 17 cell-related Pro-inflammatory responses with major depressive disorder", Basic Clin Neurosci, 7, pp.137~142 (2016)
- Chrousos GP, "A healthy body in a healthy mind--and vice versa--the damaging power of"uncontrollable"stress", J Clin Endocrinol Metab, 83, pp.1842~1845 (1998)
- Donald RA, "The plasma ACTH, AVP, CRH and catecholamine responses to conventional and laparoscopic cholecystectomy", Clin Endocrinol (Oxf), 38, pp.609~615 (1993)
- Widmer IE, "Cortisol response in relation to the severity of stress and illness", J Clin Endocrinol Metab, 90, pp.4579~4586 (2005)
- Bao AM, "Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus", Vitam Horm, 82, pp.339~365 (2010)
- Ben-Efraim YJ, "Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts", Neuropsychopharmacology, 38, pp.1504~1511 (2013)
- Katan M, "Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level", Neuro Endocrinol Lett, 29, pp.341~346 (2008)
- Itoi K, "Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus", J Neuroendocrinol, 16, pp.348~355 (2004)
- Kojima M, "Ghrelin is a growth-hormone-releasing acylated peptide from stomach", Nature, 402, pp.656~660 (1999)
- Fukushima N, "Ghrelin directly regulates bone formation", J Bone Miner Res, 20, pp.790~798 (2005)
- Wren AM, "The hypothalamic mechanisms of the hypophysiotropic action of ghrelin", Neuroendocrinology, 76, pp.316~324 (2002)
- Howard AD, "A receptor in pituitary and hypothalamus that functions in growth hormone release", Science, 273, pp.974~977 (1996)
- Khatib N, "Ghrelin: ghrelin as a regulatory Peptide in growth hormone secretion", J Clin Diagn Res, 8, pp.MC13~MC17 (2014)
- Atmaca M, "Serum ghrelin and cholesterol values in suicide attempters", Neuropsychobiology, 54, pp.59~63 (2006)
- Nakashima K, "Ghrelin gene polymorphism is associated with depression, but not panic disorder", Psychiatr Genet, 18, pp.257~ (2008)
- Kurt E, "Evaluation of serum ghrelin and leptin levels in suicide attempters", J Psychophysiol, 22, pp.76~80 (2008)
- Ishitobi Y, "Serum ghrelin levels and the effects of antidepressants in major depressive disorder and panic disorder", Neuropsychobiology, 66, pp.185~192 (2012)
- Beck AT, "Beck anxiety inventory: manual", Harcourt Brace & Company, ~ (1993)
- Ulusoy M, "Turkish version of the Beck Anxiety Inventory : psychometric properties", J Cognit Psychother, 12, pp.163~172 (1998)
- Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
- Hisli N, "Beck Depresyon Envanteri'nin üniversite öğrencileri için geçerliliği ve güvenilirliği", Turkish J Psychol, 6, pp.118~123 (1988)
- Contarino A, "Targeted mutations of the corticotropin-releasing factor system : effects on physiology and behavior", Neuropeptides, 36, pp.103~116 (2002)
- Brown GL, "Aggression, suicide, and serotonin:relationships to CSF amine metabolites", Am J Psychiatry, 139, pp.741~746 (1982)
- Brunetti L, "Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus", Eur J Pharmacol, 454, pp.189~192 (2002)
- Roy A, "Suicidal behavior, impulsiveness and serotonin", Acta Psychiatr Scand, 78, pp.529~535 (1988)
- Akinladel KS, "Serum copeptin and its diagnostic performance in schizophrenia", Afr J Med Med Sci, 43, pp.259~264 (2014)